SCHEMBL3364762

SCHEMBL3364762

CSc1ccc(-c2ccccc2N)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
HSD17B10 Q99714 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.40
DHFR P00374 1/20 0.40
CYP3A4 P08684 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
TSHR P16473 2/20 0.39
CHEK1 O14757 1/20 0.39
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
NPC1 O15118 3/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 1/20 0.37
CTSD P07339 1/20 0.36
BACE1 P56817 1/20 0.36
RAB9A P51151 2/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3787062 0.86 ALDH1A1 (0.47) ALDH1A1HSD17B10L3MBTL1DHFRCHEK1
SCHEMBL3787572 0.82 ALDH1A1 (0.47) ALDH1A1HSD17B10L3MBTL1DHFRCHEK1
SCHEMBL3789866 0.80 ALDH1A1 (0.64) ALDH1A1HSD17B10L3MBTL1DHFRCYP3A4
SCHEMBL396194 0.80 ALDH1A1 (0.52) ALDH1A1HSD17B10L3MBTL1DHFRCYP3A4
SCHEMBL20344255 0.76 HDAC1 (0.41) ALDH1A1HSD17B10L3MBTL1CYP3A4TDP1
SCHEMBL3802241 0.76 ALDH1A1 (0.52) ALDH1A1HSD17B10L3MBTL1DHFRCYP3A4
SCHEMBL394650 0.75 ALOX5AP (0.48) ALDH1A1HSD17B10L3MBTL1DHFRCYP3A4
SCHEMBL18504313 0.74 ALDH1A1 (0.54) ALDH1A1HSD17B10L3MBTL1DHFRCYP3A4
SCHEMBL10987129 0.74 ALDH1A1 (0.54) ALDH1A1HSD17B10L3MBTL1DHFRCYP3A4
SCHEMBL19320092 0.73 TDP1 (0.51) ALDH1A1HSD17B10CYP3A4TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100009970-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES COMBINATORX (SINGAPORE) PTE. LTD. (SG) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009970-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES HTR1A, HTR3B, HTR3A ALDH1A1 2240/4885HSD17B10 3252/4885L3MBTL1 1046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.